Literature DB >> 2118844

Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia.

M E North1, A D Webster, J Farrant.   

Abstract

We have assessed the ability of interleukin-2 (IL-2) and interleukin-6 (IL-6) to augment the proliferative response of T lymphocytes from 'common-variable' hypogammaglobulinaemia (CVH) patients and from normal controls, to the mitogens phytohaemagglutinin (PHA) and OKT3. We show that with cells from the control group and from those patients whose T cells respond to PHA within the control range, both IL-2 and IL-6 will significantly augment the response to OKT3. However, in those patients with a T cell defect in which the PHA response is below the control range, neither IL-2 nor IL-6 could restore the PHA or OKT3 response to normal. Responses to IL-2 or IL-6 alone were always in or above the control range.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118844      PMCID: PMC1534984          DOI: 10.1111/j.1365-2249.1990.tb05348.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Identification and function of T cells in the peripheral blood of patients with hypogammaglobulinaemia.

Authors:  A D Webster; G L Asherson
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

2.  Defective macrophage function in a patient with common variable immunodeficiency.

Authors:  M M Eibl; J W Mannhalter; G Zlabinger; W R Mayr; G P Tilz; R Ahmad; C C Zielinski
Journal:  N Engl J Med       Date:  1982-09-23       Impact factor: 91.245

3.  Production of antibody by human B cells under serum-free conditions.

Authors:  J Farrant; C A Newton; M E North; C Weyman; M K Brenner
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

4.  Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.

Authors:  M López-Botet; G Fontán; M C Garcia Rodriguez; M O de Landázuri
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

6.  Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture.

Authors:  J Farrant; J C Clark; H Lee; S C Knight; J O'Brien
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.

Authors:  M E North; G P Spickett; J Allsop; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Requirements for activation of human peripheral blood T cells by mouse monoclonal antibodies to CD3.

Authors:  D T Umetsu; D Katzen; T Chatila; R Miller; H H Jabara; M Maher; H Oettgen; C Terhorst; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1987-04

9.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.

Authors:  L Davis; P E Lipsky
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

View more
  8 in total

1.  Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.

Authors:  M E North; G P Spickett; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

Authors:  F Pandolfi; R Paganelli; A Oliva; I Quinti; V Polidori; E Fanales-Belasio; E Guerra; F Aiuti
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

3.  Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency.

Authors:  M E North; A N Akbar; N Borthwick; K Sagawa; M Funauchi; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 4.  Common variable immunodeficiency: clinical aspects and recent progress in identifying the immunological defect(s).

Authors:  M M Eibl; H M Wolf
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.

Authors:  A Franz; A Bryant; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency.

Authors:  M B Fischer; H M Wolf; H Eggenbauer; V Thon; E Vogel; J Lokaj; J Litzman; J W Mannhalter; M M Eibl
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Expression of immunoglobulin genes in common variable immunodeficiency.

Authors:  H Kaneko; N Kondo; F Motoyoshi; S Mori; Y Kobayashi; Y Inoue; T Orii
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.